Filtered By:
Specialty: OBGYN

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 345 results found since Jan 2013.

429: Echocardiographic markers aid in risk stratification of women with persistent hypertension after preeclamptic pregnancy
Women diagnosed with preeclampsia (PEC) have a higher incidence of chronic hypertension (HTN), heart failure, stroke, and other forms of cardiovascular disease. We hypothesized parameters on echocardiography (ECHO) performed at diagnosis of PEC would be associated with subsequent cardiovascular risk.
Source: American Journal of Obstetrics and Gynecology - December 25, 2018 Category: OBGYN Authors: Arthur J. Vaught, Lara C. Kovell, Dhananjay Vaidya, Pamela Ouyang, Monica Mukherjee, Sammy Zakaria Tags: Poster Session II Source Type: research

508: Readmission following discharge on labetalol or nifedipine for management of hypertensive disorders of pregnancy
Hypertensive disorders of pregnancy (HDP) confer significant maternal risks postpartum including risks of seizure, stroke and higher rates of postpartum readmission. Following delivery, women with blood pressure elevations are treated primarily with labetalol or nifedipine but it is unknown if one agent is more effective for blood pressure control following hospital discharge. We sought to compare rates of postpartum readmission and adverse maternal outcomes based on discharge on labetalol versus nifedipine.
Source: American Journal of Obstetrics and Gynecology - December 25, 2018 Category: OBGYN Authors: Samantha C. Do, Danielle M. Panelli, Anna I. Girsen, Sanaa Suharwardy, Jaclyn Estes, Ronald S. Gibbs, Yasser El- Sayed, Deirdre J. Lyell, Maurice L. Druzin, Jason Bentley Tags: Poster Session III Source Type: research

441: The burden of preeclampsia and potentially life threatening complications (PLTC) in high versus low- income countries
In Africa, nearly 1 in 10 maternal deaths are due to hypertensive disorders. In the U.S., dangerously high blood pressures are leading causes of maternal mortality/stroke, with 60% of deaths being preventable. Preeclampsia (PE)- associated morbidity and mortality is due to poor disease recognition and delay in diagnosis. Misfolded proteins are present in the urine of women with PE, and disease severity correlates with intensity with which they bind Congo red dye (congophilia). Given the differences in health care infrastructure and quality of care, we compared the frequency and spectrum of PE severity at triage evaluation ...
Source: American Journal of Obstetrics and Gynecology - December 25, 2018 Category: OBGYN Authors: Irina A. Buhimschi, Jennifer Makin, Kara M. Rood, Hillary Bracken, Catalin S. Buhimschi, Robert Pattinson Tags: Poster Session II Source Type: research

ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Authors: Abstract Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; severe diastolic hypertension; or both require urgent antihypertensive therapy. Introducing standardized, evidence-based clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to reduce the incidence of adverse maternal outcomes. Individuals and institutions should have mechanisms in place to initiate the...
Source: Obstetrics and Gynecology - December 19, 2018 Category: OBGYN Tags: Obstet Gynecol Source Type: research

Insights Into Women and Stroke Risk
Title: Insights Into Women and Stroke RiskCategory: Health NewsCreated: 12/11/2018 12:00:00 AMLast Editorial Review: 12/11/2018 12:00:00 AM
Source: MedicineNet Womens Health General - December 11, 2018 Category: OBGYN Source Type: news

Management of a pregnancy with underlying fibromuscular dysplasia with a history of stroke and carotid artery dissection.
Authors: Cunningham TK, Draper H, Rajesh U PMID: 30417729 [PubMed - as supplied by publisher]
Source: Journal of Obstetrics and Gynaecology - November 13, 2018 Category: OBGYN Tags: J Obstet Gynaecol Source Type: research

The 2017 hormone therapy position statement of The North American Menopause Society
The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North American Menopause Society and identifies future research needs. An Advisory Panel of clinicians and researchers expert in the field of women's health and menopause was recruited by NAMS to review the 2012 Position Statement, evaluate new literature, assess the evidence, and reach consensus on recommendations, using the level of evidence to identify the strength of recommendations and the quality of the evidence. The Panel's recommendations were reviewed and approved by...
Source: Menopause - October 25, 2018 Category: OBGYN Tags: Commemorative Papers Source Type: research

Association between comorbidities and female sexual dysfunction: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)
ConclusionsComorbidities were associated with FSD and specific comorbidities associated with dysfunction in specific domains. Urogynecologists and urologists must assess for comorbidities, as women presenting with sexual dysfunction may provide an opportunity for early diagnosis of life-threatening conditions.
Source: International Urogynecology Journal - September 3, 2018 Category: OBGYN Source Type: research

Breastfeeding Bonus: Lower Stroke Risk for Mom Years Later
Title: Breastfeeding Bonus: Lower Stroke Risk for Mom Years LaterCategory: Health NewsCreated: 8/22/2018 12:00:00 AMLast Editorial Review: 8/23/2018 12:00:00 AM
Source: MedicineNet Womens Health General - August 23, 2018 Category: OBGYN Source Type: news

Pattern of mortality after menopausal hormone therapy: long-term follow-up in a population based cohort.
CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant albeit weak associations differential according to both causes of death and over time underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy. This article is protected by copyright. All rights reserved. PMID: 30106241 [PubMed - as supplied by publisher]
Source: BJOG : An International Journal of Obstetrics and Gynaecology - August 14, 2018 Category: OBGYN Authors: Holm M, Olsen A, Au Yeung SL, Overvad K, Lidegaard Ø, Kroman N, Tjønneland A Tags: BJOG Source Type: research

Haemodynamic differences amongst women who were screened for gestational diabetes in comparison to healthy controls
ConclusionPregnant women at risk of GDM between gestational weeks 26 and 28 had significantly increased measures of arterial stiffness, as assessed by brachial and aortic augmentation indices, compared with low-risk healthy controls. Whether these women are at greater long-term cardiovascular disease risk warrants further investigation.
Source: Pregnancy Hypertension: An International Journal of Womens Cardiovascular Health - July 27, 2018 Category: OBGYN Source Type: research

Hormone therapy in menopausal women with fibroids: is it safe?
Menopause is an important transition in the life of women. It has been estimated that by the year 2030, worldwide 1.2 billion women will be menopausal. The most bothersome symptoms of menopause are believed to be due to declines in estrogen levels in postmenopausal women. Thus, hormone therapy is an effective treatment option for menopausal women, although prolonged use of hormone therapy is associated with a slightly increased risk of breast cancer, thromboembolism, and stroke. A literature search for studies evaluating the effects of hormone therapy in menopausal women with asymptomatic fibroids demonstrated variable eff...
Source: Menopause - July 26, 2018 Category: OBGYN Tags: Personal Perspective Source Type: research

Maternal pre-eclampsia and long-term offspring health: Is there a shadow cast?
Publication date: April 2018Source: Pregnancy Hypertension, Volume 12Author(s): Sarah M. Goffin, José G.B. Derraik, Katie M. Groom, Wayne S. CutfieldAbstractPre-eclampsia is a common pregnancy disorder with important short-term complications for mother and baby. Evidence suggests pre-eclampsia also has implications for the mother beyond pregnancy, as well as long-term effects on offspring health. Limited research has linked pre-eclampsia with changes in offspring blood pressure, BMI, and stroke risk. Underpinning mechanisms are poorly understood, but developmental programming may be involved. Research in this area has bee...
Source: Pregnancy Hypertension: An International Journal of Womens Cardiovascular Health - July 10, 2018 Category: OBGYN Source Type: research

Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: A prospective cohort study
ConclusionThe CRADLE VSA, with integrated traffic light early warning system, can identify women who are hypertensive, at increased risk of severe pre-eclampsia complications and in need of escalation of care. Women who triggered a red light were at increased risk of kidney injury, magnesium sulfate use and CCU admission.
Source: Pregnancy Hypertension: An International Journal of Womens Cardiovascular Health - July 10, 2018 Category: OBGYN Source Type: research

Preeclampsia biomarkers: An assessment of maternal cardiometabolic health
Publication date: July 2018Source: Pregnancy Hypertension, Volume 13Author(s): Genevieve Eastabrook, Tuba Aksoy, Samantha Bedell, Debbie Penava, Barbra de VrijerAbstractPreeclampsia is a serious pregnancy condition defined as new-onset hypertension and proteinuria, commonly characterized as either early, ‘placental’, or late onset, ‘maternal’, using a cut-off of 34 weeks gestation. However, it may be more useful to differentiate between the vascular remodelling and placental invasion vs. inflammation and metabolic pathophysiology that underlie these forms of preeclampsia. Due to rising rates of obesity, the late-...
Source: Pregnancy Hypertension: An International Journal of Womens Cardiovascular Health - July 10, 2018 Category: OBGYN Source Type: research